Tendinopathy: Disorders that are causes by overuse of tendons.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
236 |
4. Check minimum number of eventsNone |
236 |
5. Include endpointsNone |
236 |
6. Filter based on genotype QC (FinnGen only) |
217 |
Control definitions (FinnGen only)
- Control exclude
- M13_DORSOPATHY
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- M76
- Name in latin
- Tendinitis musculi psoae
Similar endpoints
↥List of similar endpoints to
Psoas tendinitis
based on the number of shared cases.
Similar with more cases:
- Enthesopathies of lower limb, excluding foot
- Soft tissue disorders
- Dorsopathies
- Diseases of the musculoskeletal system and connective tissue
- Any operation in hilmo
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 827 | 506 | 319 |
| Only index persons | 808 | 498 | 310 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.01 | 0.01 | 0.01 |
| Only index persons | 0.02 | 0.02 | 0.01 |
| Median age at first event (years) | |||
| Whole population | 48.04 | 49.29 | 46.15 |
| Only index persons | 47.94 | 49.19 | 45.94 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 217 | 150 | 67 |
| Unadjusted period prevalence (%) | 0.05 | 0.05 | 0.03 |
| Median age at first event (years) | 55.92 | 54.59 | 58.91 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 221
- Matched controls
- 2210
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
M76.1
ICD-10 Finland
Psoas tendinitis
+∞
320.1
221
*
NE1BG
NOMESCO Finland
Pelvic, hip and femur MRI examination with high intensity magnet
49.2
100.7
61
17
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
33.8
71.8
48
18
NF1AA
NOMESCO Finland
Hip X-ray examination
15.0
64.9
66
61
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
29.5
64.4
45
19
M16.1
ICD-10 Finland
Other primary coxarthrosis
9.8
49.8
70
100
L13
ICPC
Hip symptom/complaint
7.1
44.9
97
220
N03AX16
ATC
[U] pregabalin
6.5
34.7
72
153
M25.5
ICD-10 Finland
Pain in joint
4.6
28.6
124
478
N02AX02
ATC
tramadol; systemic, rectal
4.6
28.2
124
482
M16.0
ICD-10 Finland
Primary coxarthrosis, bilateral
8.5
28.1
40
56
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
37.5
27.8
35
11
M48.0
ICD-10 Finland
Spinal stenosis
39.7
25.0
31
9
M16
ICD-10 Finland
Coxarthrosis [arthrosis of hip]
10.6
25.0
29
31
NFF25
NOMESCO Finland
Cleaning of hip joint, arthroscopic
267.8
24.1
24
*
NFB30
NOMESCO Finland
Primary total prosthetic replacement of hip joint not using cement
8.6
24.0
33
44
M76.0
ICD-10 Finland
Gluteal tendinitis
28.5
23.8
32
13
M79.6
ICD-10 Finland
Pain in limb
4.2
23.7
143
673
N03AX12
ATC
[U] gabapentin; oral
5.8
22.5
47
98
M16.9
ICD-10 Finland
Coxarthrosis, unspecified
7.9
22.3
33
48
M54.5
ICD-10 Finland
Low back pain
4.0
22.1
98
370
N06AX21
ATC
duloxetine; oral
5.8
22.0
46
96
M01AH05
ATC
etoricoxib; oral
4.9
21.8
178
1013
NE1AA
NOMESCO Finland
Pelvis X-ray examination
7.2
19.9
32
51
M70.6
ICD-10 Finland
Trochanteric bursitis
4.8
19.7
53
137
N02BF01
ATC
gabapentin; oral
6.1
19.5
37
70
A02BC05
ATC
esomeprazole; systemic
3.5
18.7
118
548
NK5AT
NOMESCO Finland
Joint injection with ultrasound guidance not elsewhere classified
48.6
18.6
22
5
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
6.3
18.5
34
62
M54.4
ICD-10 Finland
Lumbago with sciatica
4.7
18.1
48
122
UDQ12
NOMESCO Finland
Flexible laryngoscopy
7.2
16.6
26
40
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
3.2
16.1
112
539
NE1CG
NOMESCO Finland
Pelvic, hip and femur extensive MRI examination with high intensity magnet
28.8
15.9
21
8
NFG00
NOMESCO Finland
Arthroplasty of hip joint
171.6
15.7
16
*
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
12.2
15.5
28
26
A02BC02
ATC
pantoprazole; systemic
3.7
15.4
174
1100
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
3.3
15.4
81
329
NJ3NA
NOMESCO Finland
Measurement of difference in extremity lengty with X-ray
48.7
15.3
18
*
M75.1
ICD-10 Finland
Rotator cuff syndrome
3.3
15.1
78
313
M54.9
ICD-10 Finland
Dorsalgia, unspecified
4.8
15.1
38
92
R4110, ,
SPAT
4.2
15.0
47
135
ABC36
NOMESCO Finland
Decompression of lumbar nerve roots
+∞
14.7
14
*
M47.2
ICD-10 Finland
Other spondylosis with radiculopathy
160.1
14.6
15
*
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
3.2
14.1
78
324
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
6.8
14.0
23
37
XX2AT
NOMESCO Finland
Other injection with ultrasound examination
17.7
13.8
21
13
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
80.2
13.8
15
*
Q65.88
ICD-10 Finland
Other congenital deformities of hip
+∞
13.7
13
*
NFE15
NOMESCO Finland
Plastic repair of capsule or ligament of hip joint
+∞
13.7
13
*
NE1BA
NOMESCO Finland
Pelvis extensive X-ray examination
22.9
13.6
19
9
N02AJ06
ATC
codeine and paracetamol; systemic
2.8
12.9
115
614
L03
ICPC
Low back symptom/complaint
2.9
11.7
73
320
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
3.8
11.6
39
117
R5110, ,
SPAT
4.2
11.2
32
85
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
4.0
11.1
35
100
NF2AT
NOMESCO Finland
Injection to hip joint with ultrasound guidance
29.7
10.9
14
5
M19.0
ICD-10 Finland
Primary arthrosis of other joints
3.9
10.8
35
102
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
2.6
10.8
106
582
NBG15
NOMESCO Finland
Acromioplastia, arthroscopic
5.0
10.5
24
53
NF1DA
NOMESCO Finland
X-ray of hips
17.1
10.5
16
10
M03BX02
ATC
tizanidine; oral
2.6
10.1
155
1039
NF1AA, ,
SPAT
4.8
9.8
23
52
L01
ICPC
Neck symptom/complaint
3.1
9.7
47
177
Z01.8
ICD-10 Finland
Other specified special examinations
2.8
9.6
61
268
M16.3
ICD-10 Finland
Other dysplastic coxarthrosis
31.6
9.5
12
*
M50.1
ICD-10 Finland
Cervical disc disorder with radiculopathy
16.5
9.2
14
9
M01AH01
ATC
celecoxib; oral
3.1
9.2
44
165
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
4.6
8.9
22
52
M54.2
ICD-10 Finland
Cervicalgia
4.3
8.9
24
61
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
2.5
8.7
71
350
M54.8
ICD-10 Finland
Other dorsalgia
10.7
8.7
16
16
M01AE02
ATC
naproxen; oral, rectal
2.4
8.6
145
982
NFL30
NOMESCO Finland
Transposition of muscle of hip or thigh
21.0
8.6
12
6
M35.7
ICD-10 Finland
Hypermobility syndrome
28.8
8.6
11
*
S76.1
ICD-10 Finland
Injury of quadriceps muscle and tendon
28.8
8.6
11
*
B01AF01
ATC
rivaroxaban; oral
3.2
8.6
37
130
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
4.2
8.5
24
63
G55.2*M47.9
ICD-10 Finland
Nerve root and plexus compressions in spondylosis
93.5
8.5
9
*
NFL22
NOMESCO Finland
Myotomy or tenotomy of hip or thigh
93.5
8.5
9
*
WX320
NOMESCO Finland
Spinalanesthesy
2.5
8.4
68
334
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
3.2
8.3
35
121
H02AB06
ATC
prednisolone; systemic
2.3
8.2
110
672
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
3.8
8.1
26
75
M01AB05
ATC
diclofenac; systemic, rectal
2.4
8.1
154
1085
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
2.3
8.1
108
657
M01AB55
ATC
diclofenac, combinations; oral
4.5
7.9
20
48
NE1BG, ,
SPAT
10.0
7.9
15
16
NF1AE
NOMESCO Finland
Hip joint ultrasound examination
11.4
7.9
14
13
M75.4
ICD-10 Finland
Impingement syndrome of shoulder
4.3
7.8
21
53
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
3.4
7.8
30
98
M23.9
ICD-10 Finland
Internal derangement of knee, unspecified
3.2
7.7
33
115
N04BC05
ATC
pramipexole; oral
3.8
7.7
24
68
G57.1
ICD-10 Finland
Meralgia paraesthetica
10.6
7.6
14
14
M43.1
ICD-10 Finland
Spondylolisthesis
26.0
7.6
10
*
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
2.6
7.6
50
221
N02BF02
ATC
pregabalin; oral
6.2
7.4
19
33
M01AX05
ATC
glucosamine; oral
2.7
7.4
47
204
NA3EA
NOMESCO Finland
Lumbar spine X-ray examination with flexion
+∞
7.3
7
*
WW200, ,
SPAT
2.2
7.3
81
453
N02BE01
ATC
paracetamol; systemic, rectal
4.0
7.2
206
1709
NGF25
NOMESCO Finland
Operation for osteochondritis of knee, arthroscopic
3.8
7.2
23
66
M17.1
ICD-10 Finland
Other primary gonarthrosis
2.5
7.0
51
236
M47.82
ICD-10 Finland
Other spondylosis, cervical region
14.4
7.0
11
8
A02BC01
ATC
omeprazole; systemic
2.3
6.9
63
323
M76.8
ICD-10 Finland
Other enthesopathies of lower limb, excluding foot
9.8
6.9
13
14
H81.1
ICD-10 Finland
Benign paroxysmal vertigo
3.0
6.9
33
123
M02AA07
ATC
piroxicam; topical
2.2
6.8
80
455
J01DB01
ATC
cefalexin; oral
2.9
6.7
194
1572
G55.1*M51.1
ICD-10 Finland
Compression of nerve roots and nerve plexus in disc diseases in the lumbar region and other regions
23.3
6.7
9
*
SPAT1153
SPAT
Removal of sutures
2.2
6.7
71
387
N02AA05
ATC
oxycodone; systemic
2.7
6.7
39
162
NA3BG, ,
SPAT
6.0
6.6
17
30
R01AD12
ATC
fluticasone furoate; nasal
2.1
6.5
84
494
R10.1
ICD-10 Finland
Pain localized to upper abdomen
2.5
6.5
48
223
J01CE02
ATC
phenoxymethylpenicillin; oral
2.3
6.5
165
1251
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
3.3
6.5
26
87
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
2.1
6.5
107
691
M47.9
ICD-10 Finland
Spondylosis, unspecified
71.8
6.5
7
*
B01AE07
ATC
dabigatran etexilate; oral
8.6
6.4
13
16
H02AB04
ATC
methylprednisolone; systemic
2.8
6.4
35
140
S18
ICPC
Laceration/cut
2.0
6.4
108
703
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
3.6
6.3
21
62
G50.1
ICD-10 Finland
Atypical facial pain
18.7
6.3
9
5
L28
ICPC
Limited function/disability (L)
2.6
6.3
40
173
NHL16
NOMESCO Finland
Tenolysis or tenosynovectomy of achilles tendon
+∞
6.3
6
*
SDA04
NOMESCO Finland
Demanding periodontal treatment
2.1
6.2
82
485
N02AC04
ATC
dextropropoxyphene; oral
8.0
6.2
13
17
K30
ICD-10 Finland
Functional dyspepsia
2.8
6.2
33
130
M03BC51
ATC
orphenadrine, combinations; systemic
2.2
6.2
66
360
NE1AD
NOMESCO Finland
Pelvis and hip bones CT examination
13.0
6.1
10
8
NH1BG, ,
SPAT
13.0
6.1
10
8
T84.0
ICD-10 Finland
Mechanical complication of internal joint prosthesis
10.4
6.1
11
11
SHA01
NOMESCO Finland
Stomatognathic treatment, simple
2.7
6.1
35
144
X58
ICD-10 Finland
Exposure to other specified factors
2.5
6.0
41
183
X59
ICD-10 Finland
Exposure to unspecified factor
2.4
6.0
45
210
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
87
413
2.82
12.11
2.6
2.2
—
—
—
0
0
75
333
2.90
11.79
1.4
1.3
13.37
9.03
u/ml
0.14
29
136
193
1412
3.90
11.41
6.3
3.7
9.76
10.46
mm/h
0.33
188
1311
102
544
2.63
11.08
2.5
2.3
53.48
64.19
u/l
0.71
96
505
135
827
2.63
10.94
3.1
2.6
—
—
estimate
—
0
0
112
637
2.54
10.48
3.7
3.2
19.43
32.52
ng/l
1.09
64
414
76
376
2.56
9.36
1.7
1.3
15.61
33.24
iu/ml
2.10
24
118
134
863
2.40
9.11
6.8
7.3
1.23
1.22
mmol/l
1.07
118
754
56
241
2.77
9.08
4.7
4.3
34.74
31.64
%
1.06
39
166
187
1416
3.08
8.89
8.3
7.7
72.38
76.00
u/l
0.67
177
1334
216
1881
7.55
8.70
19.3
12.4
16.79
22.74
mg/l
2.45
191
1485
91
504
2.37
8.64
2.1
2.1
111.41
175.51
u/l
1.86
85
477
33
117
3.14
7.50
1.2
1.2
—
50.79
—
0
8
191
1513
2.93
7.38
5.3
4.3
14.67
14.61
pmol/l
0.11
173
1394
150
1076
2.23
7.10
7.7
10.7
3.64
3.96
e9/l
1.33
131
936
118
773
2.13
7.04
2.1
1.9
105.24
98.80
pmol/l
0.73
62
407
139
974
2.15
6.90
4.9
3.5
0.00
0.02
estimate
0.50
22
200
17
30
6.05
6.60
2.0
1.4
—
—
—
0
0
136
971
2.04
6.11
4.9
3.5
0.00
0.00
estimate
-0.00
23
216
17
46
3.92
5.76
1.2
1.3
—
—
—
0
0
76
448
2.06
5.76
2.6
2.1
2.51
2.93
mg/l
1.33
67
372
134
966
1.98
5.69
4.9
3.5
0.00
0.00
estimate
0.50
21
216
88
551
1.99
5.61
4.0
3.0
0.00
0.02
estimate
0.74
16
163
119
829
1.94
5.53
2.6
2.5
85.40
76.28
nmol/l
2.32
104
758
113
776
1.93
5.46
5.7
6.4
1.23
1.22
mmol/l
1.39
103
724
208
1804
3.60
5.36
6.9
5.2
1.68
1.86
mu/l
1.73
190
1675
73
437
2.00
5.23
2.9
2.8
329.06
338.25
umol/l
0.31
66
390
106
739
1.83
4.67
4.3
3.4
0.00
0.03
estimate
0.96
15
175
221
2106
+∞
4.15
28.8
20.1
134.92
135.73
g/l
0.46
221
2079
221
2105
+∞
4.14
28.9
20.3
40.54
40.55
%
0.02
221
2076
221
2104
+∞
4.12
28.6
20.0
91.22
90.67
fl
1.16
221
2076
81
544
1.77
3.88
3.8
3.5
0.00
0.02
estimate
0.68
21
206
159
1302
1.79
3.67
3.2
3.3
—
—
—
0
0
13
35
3.88
3.66
1.6
1.1
—
—
—
0
0
14
46
3.18
3.60
1.1
1.1
1.60
2.77
u/ml
—
9
20
75
505
1.73
3.50
1.5
1.3
0.79
1.26
u/ml
0.72
15
136
42
238
1.94
3.41
1.6
1.6
1132.61
1097.64
nmol/l
0.08
28
175
29
144
2.17
3.34
1.1
1.3
—
—
—
0
0
11
28
4.08
3.33
1.0
1.0
0.01
0.02
u/ml
—
5
6
13
39
3.48
3.28
2.0
1.2
4207.63
24824.04
e6/l
—
8
28
11
30
3.80
3.13
1.6
1.7
5.02
5.71
mmol/24h
0.23
11
25
70
477
1.68
3.08
3.0
3.2
816.95
959.59
ng/l
0.26
58
407
206
1873
2.47
3.03
16.8
12.3
82.73
85.11
ml/min/173m2
0.92
185
1703
72
498
1.66
2.98
1.6
1.5
19.67
21.42
nmol/l
0.41
58
428
161
1362
1.67
2.88
3.7
3.0
45.81
41.09
u/l
0.24
149
1294
60
402
1.68
2.78
1.5
1.7
0.70
1.09
mg/l
1.11
46
307
12
44
2.83
2.59
1.0
1.3
326.16
295.37
ug/g
—
5
25
128
1040
1.55
2.58
4.2
4.3
6.16
6.57
mmol/l
1.91
122
971
5
7
7.27
2.56
1.6
1.0
5.28
5.84
mmol/l
—
5
7
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
12
5.11
2.42
1.0
1.3
—
—
—
0
0
206
1902
2.22
2.40
5.1
4.8
4.76
4.71
mmol/l
0.34
190
1779
43
275
1.70
2.35
2.3
3.9
0.81
0.81
mmol/l
0.07
38
261
15
66
2.37
2.30
1.5
1.9
—
—
—
0
0
8
23
3.57
2.29
1.9
1.6
—
—
—
0
0
42
270
1.69
2.25
3.6
2.7
4.08
3.93
e6/l
0.02
21
130
11
41
2.77
2.24
4.2
2.4
1.10
1.42
mmol/l
1.43
11
41
5
9
5.65
2.22
1.8
2.0
—
—
—
0
0
8
24
3.42
2.20
1.9
1.5
—
—
—
0
0
8
24
3.42
2.20
1.9
1.5
—
—
—
0
0
8
24
3.42
2.20
1.9
1.5
—
—
—
0
0
8
24
3.42
2.20
1.9
1.5
—
—
—
0
0
8
24
3.42
2.20
1.9
1.5
—
—
—
0
0
207
1926
2.18
2.17
6.0
5.4
2.76
2.77
mmol/l
0.05
188
1799
5
10
5.09
2.08
1.0
2.4
68.80
111.70
nmol/l
—
5
10
5
10
5.09
2.08
1.0
1.2
—
—
—
0
0
15
70
2.23
2.03
1.3
2.2
—
—
—
0
0
204
1898
1.97
1.98
5.3
4.7
1.58
1.51
mmol/l
1.50
187
1772
7
21
3.41
1.98
1.0
1.1
—
—
—
0
0
199
1840
1.82
1.93
5.6
4.6
5.71
5.83
mmol/l
1.00
177
1693
196
1807
1.75
1.89
4.5
4.0
1.21
1.25
mmol/l
0.38
177
1679
5
12
4.24
1.83
1.2
3.5
6.02
3.54
nmol/l
—
5
12
93
744
1.43
1.83
4.8
4.4
37.04
36.41
g/l
0.68
85
703
8
30
2.73
1.74
1.5
1.4
—
—
—
0
0
59
438
1.47
1.70
1.8
1.6
—
—
—
0
0
6
19
3.22
1.67
1.0
1.1
—
—
—
0
0
31
200
1.64
1.65
5.0
6.9
104.42
104.58
mmol/l
0.06
31
200
23
137
1.76
1.63
1.3
1.2
81.13
201.91
u/ml
1.13
23
127
25
153
1.71
1.61
1.3
1.3
166.10
160.65
u/ml
—
10
65
6
20
3.05
1.59
1.0
1.2
—
—
—
0
0
6
20
3.05
1.59
1.0
1.1
—
—
—
0
0
192
1779
1.60
1.58
6.9
5.7
37.87
38.60
mmol/mol
0.68
177
1673
10
44
2.33
1.58
1.4
1.3
—
36.84
—
0
7
41
287
1.53
1.56
3.4
2.7
1.19
1.12
e6/l
0.06
20
145
29
188
1.62
1.52
2.9
5.8
—
—
—
0
0
24
148
1.70
1.52
2.8
2.4
0.02
0.17
e6/l
3.34
24
138
21
125
1.75
1.50
1.0
1.0
—
—
—
0
0
5
16
3.17
1.44
1.6
1.1
—
—
—
0
0
5
16
3.17
1.44
1.6
1.1
—
—
—
0
0
19
111
1.78
1.44
1.3
2.3
15.42
51.25
u/ml
1.05
19
106
15
81
1.91
1.44
2.3
1.7
—
—
—
0
0
11
53
2.13
1.41
1.3
1.2
—
—
—
0
0
10
48
2.13
1.30
1.1
1.4
12.20
17.45
e6/l
—
5
33
10
48
2.13
1.30
1.1
1.5
121.00
82.00
e6/l
—
5
35
11
57
1.98
1.19
1.6
1.5
—
—
—
0
0
15
88
1.76
1.14
2.7
4.4
2.00
2.06
mmol/l
—
9
71
45
342
1.40
1.14
1.7
1.7
430.92
40484865.82
pmol/l
0.50
38
289
7
32
2.23
1.09
1.0
1.3
—
—
—
0
0
14
82
1.76
1.08
5.3
3.7
36.44
48.40
%
0.84
14
82
78
653
1.30
1.05
2.5
3.1
28.96
28.65
u/l
0.06
73
619
25
173
1.50
1.03
3.8
4.9
2.04
34.35
ug/l
0.67
18
135
58
468
1.32
1.01
3.9
2.9
0.27
0.42
e6/l
0.59
39
320
9
49
1.87
1.00
1.0
1.3
—
—
—
0
0
9
51
1.80
0.96
2.2
2.5
—
—
—
0
0
37
281
1.38
0.95
2.0
2.2
—
—
—
0
0
19
126
1.56
0.95
2.2
1.5
—
—
—
0
0
6
28
2.17
0.92
2.7
2.5
6.67
5.74
pmol/l
—
6
28
6
30
2.03
0.87
1.0
1.6
0.28
0.32
nmol/l
—
6
24
33
250
1.38
0.87
2.1
2.1
—
—
—
0
0
12
73
1.68
0.83
1.6
1.4
—
—
—
0
0
6
32
1.90
0.82
1.0
1.7
—
—
—
0
0
15
99
1.55
0.78
1.9
1.4
—
—
—
0
0
6
34
1.79
0.77
1.2
1.1
—
1.66
—
0
7
13
84
1.58
0.73
3.8
4.2
24.87
24.27
mmol/l
0.34
13
84
5
26
1.94
0.71
1.4
1.0
—
—
—
0
0
50
418
1.25
0.67
4.5
3.5
1.02
1.02
kg/l
0.19
38
274
66
573
1.22
0.63
3.5
4.3
8.54
10.97
mg/mmol
0.14
40
351
19
139
1.40
0.63
1.3
3.3
86.75
66.71
ml/min/173m2
—
8
55
13
88
1.51
0.62
2.8
2.9
0.58
0.64
%
0.35
13
88
41
340
1.25
0.59
4.3
4.0
24.53
21.40
%
0.64
18
164
13
90
1.47
0.57
2.8
2.9
0.90
1.20
%
1.19
13
90
33
270
1.26
0.54
2.4
1.9
—
—
—
0
0
69
611
1.19
0.53
3.0
3.2
2.35
2.36
mmol/l
0.22
62
562
31
252
1.27
0.53
4.3
2.9
0.97
0.77
ug/l
0.32
16
163
6
100
0.59
0.53
3.3
3.1
147.50
168.95
ng/l
—
6
94
12
87
1.40
0.43
5.7
9.9
24.24
25.01
mmol/l
0.46
12
87
42
364
1.19
0.41
1.6
1.6
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
0
15
0.00
0.41
0.0
1.8
—
130.27
—
0
15
0
19
0.00
0.39
0.0
1.8
—
—
—
0
0
31
264
1.20
0.37
1.8
2.3
29.94
29.26
s
0.29
31
256
22
263
0.82
0.34
2.0
2.0
3.30
3.34
ratio
0.07
16
200
6
46
1.31
0.33
1.8
1.2
—
—
—
0
0
7
52
1.36
0.31
1.4
1.1
—
—
—
0
0
7
52
1.36
0.31
1.4
1.1
—
—
—
0
0
12
97
1.25
0.23
1.3
1.4
—
—
—
0
0
17
198
0.85
0.21
1.8
1.8
3.62
3.41
mmol/l
0.36
11
140
0
11
0.00
0.21
0.0
1.1
—
89.00
—
0
6
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
0
11
0.00
0.21
0.0
1.1
—
112.64
—
0
11
0
10
0.00
0.21
0.0
1.7
—
14.60
—
0
10
0
10
0.00
0.21
0.0
1.7
—
—
—
0
0
0
12
0.00
0.21
0.0
1.6
—
—
—
0
0
0
12
0.00
0.21
0.0
1.2
—
99.00
—
0
7
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
0
14
0.00
0.20
0.0
1.2
—
911.62
—
0
14
0
14
0.00
0.20
0.0
1.6
—
3.13
—
0
8
0
14
0.00
0.20
0.0
1.6
—
—
—
0
0
6
49
1.23
0.20
2.3
1.5
—
—
—
0
0
19
166
1.16
0.18
3.0
2.8
—
—
—
0
0
7
59
1.19
0.18
1.3
1.7
0.00
0.40
g/l
—
7
53
7
62
1.13
0.17
2.0
1.4
—
—
—
0
0
8
95
0.84
0.14
1.1
1.1
1.53
1.58
g/l
—
8
95
8
97
0.82
0.14
1.1
1.1
0.96
0.88
g/l
—
8
97
10
87
1.16
0.09
1.1
1.3
—
—
—
0
0
84
816
1.05
0.09
1.8
1.9
1.23
1.32
mmol/l
0.60
71
697
6
57
1.05
0.08
1.5
3.0
25.10
24.79
mmol/l
—
6
57
9
85
1.06
0.07
1.8
1.6
—
—
—
0
0
8
92
0.86
0.07
1.0
1.4
271.00
315.68
mu/l
—
8
87
164
1633
1.02
0.01
21.4
16.5
332.00
332.25
g/l
0.15
164
1624
20
194
1.03
0.00
3.0
1.6
—
—
—
0
0
14
141
0.99
0.00
2.1
1.9
—
—
—
0
0
32
324
0.99
0.00
4.3
3.4
15.21
476.64
ng/l
1.41
19
229
18
185
0.97
0.00
3.2
1.7
—
—
—
0
0
17
168
1.01
0.00
2.3
2.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
0.19
—
0
6
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
115.33
—
0
6
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.1
—
1.09
—
0
8
0
8
0.00
-0.00
0.0
3.1
—
44.70
—
0
8
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.7
—
—
—
0
0
9
92
0.98
-0.00
1.2
2.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.7
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.6
—
6.08
—
0
5
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
19.94
—
0
8
0
9
0.00
-0.00
0.0
2.3
—
127.78
—
0
9
5
59
0.84
-0.00
1.6
1.7
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint M13_PSOASTEND and mortality.
Females
No dataMales
No dataMortality risk
Mortality risk for people of age
years, who have M13_PSOASTEND.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | No data |
| 5 | No data | No data |
| 10 | No data | No data |
| 15 | No data | No data |
| 20 | No data | No data |
Relationships between endpoints
↥Index endpoint: M13_PSOASTEND – Psoas tendinitis
GWS hits: 1
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data